Intuitive Surgical, Inc. Stock

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:01 2024-05-03 pm EDT 5-day change 1st Jan Change
381.4 USD +0.98% Intraday chart for Intuitive Surgical, Inc. +1.61% +13.04%
Sales 2024 * 8.03B Sales 2025 * 9.31B Capitalization 135B
Net income 2024 * 1.97B Net income 2025 * 2.27B EV / Sales 2024 * 16.2 x
Net cash position 2024 * 5.19B Net cash position 2025 * 7.75B EV / Sales 2025 * 13.7 x
P/E ratio 2024 *
68.9 x
P/E ratio 2025 *
60.2 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.98%
1 week+1.61%
Current month+2.90%
1 month-0.54%
3 months-0.63%
6 months+36.92%
Current year+13.04%
More quotes
1 week
367.39
Extreme 367.385
384.47
1 month
364.17
Extreme 364.17
393.66
Current year
320.26
Extreme 320.26
403.76
1 year
254.85
Extreme 254.85
403.76
3 years
180.07
Extreme 180.07
403.76
5 years
120.17
Extreme 120.1667
403.76
10 years
38.50
Extreme 38.4956
403.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
President 56 96-02-29
Director of Finance/CFO 52 13-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-03-31
Director/Board Member 66 07-10-18
Director/Board Member 71 10-03-31
More insiders
Date Price Change Volume
24-05-03 381.4 +0.98% 1,028,858
24-05-02 377.6 +1.60% 1,208,612
24-05-01 371.7 +0.29% 952,256
24-04-30 370.6 -0.94% 1,213,211
24-04-29 374.1 -0.32% 983,225

Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
381.4 USD
Average target price
420.4 USD
Spread / Average Target
+10.23%
Consensus